Speaker illustration

Doctor Yoshitaka Kimura

Leiden University Medical Center, Leiden (Netherlands (The))

Member of:

European Society of Cardiology
European Heart Rythm Association

Impact of functional gene groups on outcomes after ablation of ventricular tachycardia in patients with inherited left ventricular cardiomyopathy: an international multicentre study

Event: EHRA 2024

Topic: Ablation of Ventricular Arrhythmias

Session: Ventricular tachycardia: ablation

Thumbnail

The impact of electroanatomical mapping and VT substrate ablation on primary and secondary prevention ICD indication in patients with repaired Tetralogy of Fallot

Event: EHRA 2023

Topic: Ablation of Ventricular Arrhythmias

Session: Ventricle - Round 2 - Ablation

Thumbnail

Non-invasive identification of slow conducting anatomical isthmuses in patients with tetralogy of Fallot by 3D late gadolinium enhancement cardiovascular magnetic resonance

Event: EHRA 2022

Topic: Congenital Heart Disease and Paediatric Cardiology, Other

Session: Electrophysiology with news on various topics

Thumbnail

Pleomorphic ventricular tachycardia in dilated cardiomyopathy is a strong predictor of VT recurrence after ablation independent of cardiac function: Comparison with ischemic cardiomyopathy

Event: EHRA 2021

Topic: Ablation of Ventricular Arrhythmias

Session: New insights in ventricular arrhythmias II

Thumbnail

Volume-weighted unipolar endocardial voltage: An excellent, novel parameter for predicting cardiac mortality in patients with dilated cardiomyopathy and ventricular arrhythmias

Event: EHRA 2021

Topic: Ablation of Ventricular Arrhythmias

Session: New insights in ventricular arrhythmias I

Thumbnail

Impact of VT pleomorphism on the prognostic value of non-inducibility after catheter ablation in patients with non-ischemic cardiomyopathy

Event: ESC Congress 2019

Topic: Ablation of Ventricular Arrhythmias

Session: Catheter ablation of ventricular arrhythmias

Thumbnail

Clinical impacts of wide ORS morphologies on deterioration of left ventricular ejection fraction and fatal arrhythmias in patients with relatively preserved left ventricular ejection function

Event: ESC Congress 2018

Topic: Risk Factors and Risk Assessment

Session: Is there any progress in risk stratification for sudden cardiac death?

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb